Lothar Müller

3.0k total citations
71 papers, 850 citations indexed

About

Lothar Müller is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Lothar Müller has authored 71 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 38 papers in Pulmonary and Respiratory Medicine and 15 papers in Cancer Research. Recurrent topics in Lothar Müller's work include Colorectal Cancer Treatments and Studies (17 papers), Advanced Breast Cancer Therapies (16 papers) and Cancer Treatment and Pharmacology (16 papers). Lothar Müller is often cited by papers focused on Colorectal Cancer Treatments and Studies (17 papers), Advanced Breast Cancer Therapies (16 papers) and Cancer Treatment and Pharmacology (16 papers). Lothar Müller collaborates with scholars based in Germany, Switzerland and Austria. Lothar Müller's co-authors include Martina Stauch, Jens Stieler, Uwe Pelzer, S. Hahnfeld, P Reitzig, Helmut Oettle, Bernhard Opitz, Norbert Marschner, Hanno Riess and G. Deutschinoff and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Lothar Müller

67 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lothar Müller Germany 13 424 269 197 163 131 71 850
Joseph Sgouros Greece 14 347 0.8× 118 0.4× 263 1.3× 120 0.7× 58 0.4× 34 724
Thomas J. Semrad United States 15 395 0.9× 237 0.9× 135 0.7× 257 1.6× 162 1.2× 51 890
Michele De Tursi Italy 18 576 1.4× 310 1.2× 340 1.7× 239 1.5× 304 2.3× 60 1.3k
Roberto Moretto Italy 15 623 1.5× 207 0.8× 110 0.6× 124 0.8× 144 1.1× 69 872
Marianne Sinn Germany 12 511 1.2× 195 0.7× 263 1.3× 44 0.3× 194 1.5× 34 807
H. Kröning Germany 13 1.0k 2.5× 592 2.2× 134 0.7× 179 1.1× 120 0.9× 26 1.5k
Matteo Brighenti Italy 12 628 1.5× 316 1.2× 66 0.3× 182 1.1× 63 0.5× 38 869
Margot J. Burnell Canada 12 649 1.5× 254 0.9× 225 1.1× 116 0.7× 420 3.2× 32 1.1k
Charles Kuzma United States 11 697 1.6× 261 1.0× 391 2.0× 168 1.0× 518 4.0× 20 1.3k
Jane Liang United States 14 726 1.7× 629 2.3× 303 1.5× 320 2.0× 84 0.6× 23 1.2k

Countries citing papers authored by Lothar Müller

Since Specialization
Citations

This map shows the geographic impact of Lothar Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lothar Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lothar Müller more than expected).

Fields of papers citing papers by Lothar Müller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lothar Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lothar Müller. The network helps show where Lothar Müller may publish in the future.

Co-authorship network of co-authors of Lothar Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Lothar Müller. A scholar is included among the top collaborators of Lothar Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lothar Müller. Lothar Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ballhausen, Alexej, David Horst, Ullrich Graeven, et al.. (2025). Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti–EGFR-Based Maintenance for RAS wt Metastatic CRC—The PanaMa (AIO KRK0212) Trial. Clinical Cancer Research. 31(19). 4049–4058. 1 indexed citations
2.
Potthoff, Karin, Norbert Marschner, Lothar Müller, et al.. (2025). Final Results of ERBIMOX: A Randomized Phase II Study of Modified FOLFOX7 With or Without Cetuximab as First-Line Treatment for KRAS Wild-type Metastatic Colorectal Cancer. Journal of Gastrointestinal Cancer. 56(1). 141–141.
3.
Stahler, Arndt, Christine Sers, Soulafa Mamlouk, et al.. (2024). Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212). Clinical Cancer Research. 30(7). 1256–1263. 9 indexed citations
4.
Untch, Michael, Nina Ditsch, Peter A. Fasching, et al.. (2024). Discussion of ABC7 Consensus and German Recommendations. Geburtshilfe und Frauenheilkunde. 84(5). 431–442. 1 indexed citations
5.
Ekmekçiu, Ira, Bülent Sargin, Stephan Hollerbach, et al.. (2024). Exploring the molecular profile of localized colon cancer: insights from the AIO Colopredict Plus registry. Frontiers in Oncology. 14. 1434791–1434791. 1 indexed citations
6.
Heinrich, Kathrin, Volker Heinemann, Sebastian Stintzing, et al.. (2024). Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114). Oncology Research and Treatment. 47(6). 251–261. 1 indexed citations
7.
Ditsch, Nina, Michael Untch, Peter A. Fasching, et al.. (2024). ABC7 Consensus: Assessment by a German Group of Experts. Breast Care. 19(2). 116–128. 1 indexed citations
8.
9.
Riecke, Armin, Eugen Tausch, Deyan Y. Yosifov, et al.. (2023). Genetic markers and ibrutinib vs placebo treatment in early stage chronic lymphocytic leukemia -results from the GCLLSG CLL12 trial. Blood. 142(Supplement 1). 199–199.
10.
11.
Müller, Lothar, et al.. (2022). Influence of the skeletal muscle index on pharmacokinetics and toxicity of fluorouracil. Cancer Medicine. 12(3). 2580–2589. 4 indexed citations
12.
Groenland, Stefanie L., Alwin D. R. Huitema, Neeltje Steeghs, et al.. (2021). Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol. Cancers. 13(24). 6281–6281. 14 indexed citations
13.
Rinke, Anja, Christoph Maintz, Lothar Müller, et al.. (2021). Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and Austria. Experimental and Clinical Endocrinology & Diabetes. 129(7). 500–509. 5 indexed citations
14.
15.
Untch, Michael, Doris Augustin, Johannes Ettl, et al.. (2016). ABC3 Consensus Commented from the Perspective of the German Guidelines. Geburtshilfe und Frauenheilkunde. 76(2). 156–163. 7 indexed citations
16.
Marschner, Norbert, Michael Staehler, Lothar Müller, et al.. (2016). Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials—Analyses From the German Clinical RCC Registry. Clinical Genitourinary Cancer. 15(2). e209–e215. 44 indexed citations
17.
Maurer, Christian, Petra Langerbeins, Jasmin Bahlo, et al.. (2016). Effect of first-line treatment on second primary malignancies and Richter’s transformation in patients with CLL. Leukemia. 30(10). 2019–2025. 35 indexed citations
18.
Thomssen, Christoph, Doris Augustin, Johannes Ettl, et al.. (2016). ABC3 Consensus: Assessment by a German Group of Experts. Breast Care. 11(1). 61–70. 7 indexed citations
19.
20.
Müller, Lothar, et al.. (2007). Bilddiagnostik der Netzhaut mit der Funduskamera. Zeitschrift für Medizinische Physik. 17(1). 67–72. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph Sgouros Breakdown of academic impact, for papers by Thomas J. Semrad Breakdown of academic impact, for papers by Michele De Tursi Breakdown of academic impact, for papers by Roberto Moretto Breakdown of academic impact, for papers by Marianne Sinn Breakdown of academic impact, for papers by H. Kröning Breakdown of academic impact, for papers by Matteo Brighenti Breakdown of academic impact, for papers by Margot J. Burnell Breakdown of academic impact, for papers by Charles Kuzma Breakdown of academic impact, for papers by Jane Liang
Rankless by CCL
2026